Lance Liotta
Lance A. Liotta (born July 12, 1947)[1] is the Co-Director and Co-Founder of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University.[3] His research team was the first to propose the existence of the autocrine motility factor. In 1985, he received the Rhoads Award (since renamed the Award for Outstanding Achievement in Cancer Research) from the American Association for Cancer Research. In 1987, he received the National Lectureship Award from the American Association for Clinical Chemistry. His other awards include the Warner-Lambert Parke Davis Award and the Surgeon General's Medallion.[2][3]
Lance Liotta | |
|---|---|
| Born | July 12, 1947[1] |
| Nationality | American |
| Education | Hiram College Case Western Reserve University |
| Known for | Autocrine motility factor |
| Awards | National Lectureship Award from the American Association for Clinical Chemistry (1987) |
| Scientific career | |
| Fields | Biology |
| Institutions | George Mason University |
| Thesis | System dynamics of the hematogenous metastatic process from an implanted tumor (1974) |
References
- Information, National Institutes of Health (U S. ) Division of Public (1998). NIH Almanac. U.S. Department of Health, Education and Welfare, Public Health Service, National Institutes of Health. p. 48.
- "Lance A. Liotta". American Association for Clinical Chemistry. Retrieved 2019-12-24.
- "CAPMM Team". Center for Applied Proteomics and Molecular Medicine. Retrieved 2019-12-24.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.